A New York bankruptcy judge approved a disclosure statement last week laying out Purdue Pharma’s proposed reorganization plan – despite an objection alleging the disclosure omits information about the US government’s plan to seize Purdue money that could be used to compensate prescription opioid victims under the Mandatory Victims Restitution Act instead.
It’s been five years since Purdue Pharma pleaded guilty to charges of conspiracy in a New Jersey federal court, including for unlawfully dispensing opioid products without a legitimate medical purpose. In a press release at the time, the Department of Justice emphasized that the convictions were part of a strategy to defeat the opioid crisis.
